Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

Abstract

Highlights The years after the first diagnosis and progressive or non-progressive MS are crucial factors in increasing the risk of early AD. The florbetapir-based radio traces in helping to diagnose early AD. Logical to use an age-specific cutoff in MS patients for early AD diagnosis.

Keywords

• Neurodegenerative disease
• Neuroinflammation
• Neuroimaging
• Dementia
• Alzheimer's disease
• Multiple sclerosis